ABOUT

The Texas Healthcare & Bioscience Institute (THBI) works to promote effective legislation and a steady regulatory environment at the state and federal levels. With a focus on using advocacy as a tool to create a more favorable business environment for various healthcare entities, we work with government and industry leaders to attract new participants in the life sciences.

 

Our members not only have a voice at the Capitol through our revered legislative team, but they also benefit from extensive networking in the healthcare space across Texas. THBI is the leading health policy voice in the state, influencing legislation that has led to economic investment and medical breakthroughs for over 20 years.

THBI LEADERSHIP

Thomas R. Kowalski

President & CEO

Andrea Giuffrida, PhD

Vice Chairman | UT Health San Antonio

Bradley Westmoreland

Treasurer | Genentech, Inc.


Holli Hill

Novartis Pharmaceuticals

Mark Moreno
The University of Texas MD Anderson
Cancer Center


Joan Solem

Eli Lilly & Company

David R. Margrave
Chairman | Trinita Life Science Advisors

Holly Jacques Turner
Secretary | Merck

Jeff Buel 
Johnson & Johnson

Ryan Garofalo
PhRMA

Kyle Kamrath

Vertex Pharmaceuticals

Amber Pearce
Pfizer

Jeffrey L. Wade

Lexicon Pharmaceuticals

THBI EXECUTIVE STAFF

Thomas R. Kowalski

President & CEO
Email


Julia Perkins

Director of Membership & Programming
Email

Meredith Armstrong
Policy Director
Email


Virginia Rothenflue
Director of Operations
Email